Katholisches Klinikum Mainz
Mainz, Germany
General hospital in Mainz, Rhineland-Palatinate
An d. Goldgrube 11, 55131 Mainz
About Katholisches Klinikum Mainz
"Schwerpunktversorgung und akademisches Lehrkrankenhaus in Mainz"
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
2
Pfizer
2
AGO Research GmbH
1
Boston Scientific Corporation
1
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
1
LungenClinic Grosshansdorf
1
NTC srl
1
Pantarhei Oncology B.V.
1
ReCor Medical, Inc.
1
Shockwave Medical, Inc.
1
University of Bergen
1
Clinical Trials at Katholisches Klinikum Mainz
During the past decade, Katholisches Klinikum Mainz conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 4 clinical trials were completed, i.e. on
average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Erlotinib Versus Carboplatin/Vinorelbine in Elderly Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
2006-06-01
Unknown status
260
A Study of Palbociclib (PD-0332991) + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer (PALOMA-2)
2013-02-22
2023-08-26
Active, not recruiting
666
Post Market Observational, Prospective, Multi-center Study
2013-05-01
2019-07-01
Terminated
1,275
Study Of The Blood Thinner, Apixaban, For Patients Who Have An Abnormal Heart Rhythm (Atrial Fibrillation) And Expected To Have Treatment To Put Them Back Into A Normal Heart Rhythm (Cardioversion)
2014-07-14
2017-02-08
Completed
1,500
A Study of the ReCor Medical Paradise System in Clinical Hypertension
2016-03-01
2025-05-01
Active, not recruiting
292
Assessment of Safety and Efficacy of Estetrol in Postmenopausal Women With Advanced Estrogen Receptor Positive (ER+) Breast Cancer
2017-06-01
2019-12-31
Completed
12
Shockwave Medical Peripheral Lithoplasty System Study for PAD (Disrupt PAD III)
2017-02-22
2022-06-02
Completed
306
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
2017-03-02
2021-04-26
Completed
5,988
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Katholisches Klinikum Mainz" #1 sponsor was "Boehringer Ingelheim" with 2 trials, followed by "Pfizer" with 2 trials
sponsored, "AGO Research GmbH" with 1 trials sponsored, "Boston Scientific Corporation" with 1 trials sponsored and "Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company"
with 1 trials sponsored. Other sponsors include 1 different institutions and
companies that sponsored additional 11 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Katholisches Klinikum Mainz"
#1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Mutualista Asociación Hospital Evangélico" with 1 trials as a collaborator, "Pallium Latinoamérica N.G.O" with 1 trials as a collaborator and "PneumRx, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 9 trials.
Clinical Trials Conditions at Katholisches Klinikum Mainz
According to Clinical.Site data, the most researched conditions in "Katholisches Klinikum Mainz" are
"Breast Neoplasms" (2 trials), "Atrial Fibrillation" (1 trials), "Bereavement" (1 trials), "Elective Colonoscopy" (1 trials) and "Emphysema" (1 trials). Many other conditions were trialed in "Katholisches Klinikum Mainz" in a lesser frequency.
Clinical Trials Intervention Types at Katholisches Klinikum Mainz
Most popular intervention types in "Katholisches Klinikum Mainz" are "Drug" (10 trials) and "Device" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Empagliflozin" (2 trials), "Apixaban" (1 trials), "Bempedoic acid and/or its fixed-dose combination with ezetimibe" (1 trials) and "Bevacizumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Katholisches Klinikum Mainz
The vast majority of trials in "Katholisches Klinikum Mainz" are
10 trials for "All" genders and 3 trials for "Female" genders.
Clinical Trials Status at Katholisches Klinikum Mainz
Currently, there are NaN active trials in "Katholisches Klinikum Mainz".
undefined are not yet recruiting,
1 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Katholisches Klinikum Mainz,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Katholisches Klinikum Mainz, 1 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 2 trials that are defined as “Not Applicable".